Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Medical School, University of Chile, and Cardiovascular Department, Clinical Hospital, Santiago, Chile.
Pharmacol Rep. 2013;65(1):80-8. doi: 10.1016/s1734-1140(13)70966-6.
The combination of two analgesic agents offers advantages in pain treatment. Codeine and morphine analgesia is due to activation of opioid receptor subtypes.
This study, performed in mice using isobolographic analysis, evaluated the type of interaction in intraperitoneal (ip) or intrathecal (it) coadministration of codeine and morphine, in three nociceptive behavioral models.
Intrathecal morphine resulted to be 7.5 times more potent than ip morphine in the writhing test, 55.6 times in the tail flick test and 1.7 times in phase II of the orofacial formalin test; however, in phase I of the same test ip was 1.2 times more potent than it morphine. Intrathecal codeine resulted being 3.4 times more potent than ip codeine in the writhing test, 1.6 times in the tail flick test, 2.5 times in phase I and 6.7 times in phase II of the orofacial formalin test. Opioid coadministration had a synergistic effect in the acute tonic pain (acetic acid writhing test), acute phasic pain (tail flick test) and inflammatory pain (orofacial formalin test). The interaction index ranged between 0.284 (writhing ip) and 0.440 (orofacial formalin phase II ip).
This synergy may relate to the different pathways of pain transmission and to the different intracellular signal transduction. The present findings also raise the possibility of potential clinical advantages in combining opioids in pain management.
两种镇痛剂的联合使用在疼痛治疗中具有优势。可待因和吗啡的镇痛作用是通过激活阿片受体亚型实现的。
本研究采用立体定位分析,在三种疼痛行为模型中评估了鞘内(it)和腹腔内(ip)联合使用可待因和吗啡的相互作用类型。
鞘内吗啡在扭体试验中的效力是腹腔内吗啡的 7.5 倍,在甩尾试验中是 55.6 倍,在口腔面部福尔马林试验的第二期是 1.7 倍;然而,在同一试验的第一期中,腹腔内吗啡的效力是鞘内吗啡的 1.2 倍。鞘内可待因在扭体试验中的效力是腹腔内可待因的 3.4 倍,在甩尾试验中是 1.6 倍,在口腔面部福尔马林试验的第一期是 2.5 倍,第二期是 6.7 倍。阿片类药物联合使用在急性强直性疼痛(醋酸扭体试验)、急性相疼痛(甩尾试验)和炎症性疼痛(口腔面部福尔马林试验)中具有协同作用。相互作用指数范围为 0.284(扭体 ip)至 0.440(口腔面部福尔马林第二期 ip)。
这种协同作用可能与疼痛传递的不同途径和不同的细胞内信号转导有关。本研究结果还提出了在疼痛管理中联合使用阿片类药物可能具有潜在临床优势的可能性。